AT441417T - Benzoedetazepine derivatives for the treatment of neurological diseases - Google Patents

Benzoedetazepine derivatives for the treatment of neurological diseases

Info

Publication number
AT441417T
AT441417T AT03785885T AT03785885T AT441417T AT 441417 T AT441417 T AT 441417T AT 03785885 T AT03785885 T AT 03785885T AT 03785885 T AT03785885 T AT 03785885T AT 441417 T AT441417 T AT 441417T
Authority
AT
Austria
Prior art keywords
benzoedetazepine
derivatives
treatment
neurological diseases
neurological
Prior art date
Application number
AT03785885T
Other languages
German (de)
Inventor
Mark Bamford
David Dean
Sanjeet Sehmi
David Wilson
Jason Witherington
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0229820A priority Critical patent/GB0229820D0/en
Priority to GB0312607A priority patent/GB0312607D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to PCT/EP2003/014556 priority patent/WO2004056369A1/en
Publication of AT441417T publication Critical patent/AT441417T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
AT03785885T 2002-12-20 2003-12-18 Benzoedetazepine derivatives for the treatment of neurological diseases AT441417T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0229820A GB0229820D0 (en) 2002-12-20 2002-12-20 Novel compounds
GB0312607A GB0312607D0 (en) 2003-06-02 2003-06-02 Novel compounds
PCT/EP2003/014556 WO2004056369A1 (en) 2002-12-20 2003-12-18 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders

Publications (1)

Publication Number Publication Date
AT441417T true AT441417T (en) 2009-09-15

Family

ID=32683982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03785885T AT441417T (en) 2002-12-20 2003-12-18 Benzoedetazepine derivatives for the treatment of neurological diseases

Country Status (28)

Country Link
US (4) US7696193B2 (en)
EP (3) EP1572215B1 (en)
JP (2) JP4584831B2 (en)
KR (2) KR100765027B1 (en)
AR (1) AR042542A1 (en)
AT (1) AT441417T (en)
AU (1) AU2003294909B2 (en)
BR (1) BR0317483A (en)
CA (1) CA2509413C (en)
CY (1) CY1109558T1 (en)
DE (1) DE60329123D1 (en)
DK (1) DK1572215T3 (en)
EG (1) EG25204A (en)
ES (3) ES2401319T3 (en)
HK (1) HK1085647A1 (en)
IL (2) IL169091A (en)
IS (1) IS2907B (en)
MA (1) MA27582A1 (en)
MX (1) MXPA05006567A (en)
MY (1) MY138478A (en)
NO (2) NO331068B1 (en)
NZ (1) NZ540148A (en)
PL (2) PL220722B1 (en)
PT (1) PT1572215E (en)
RU (2) RU2388752C2 (en)
SI (1) SI1572215T1 (en)
TW (1) TWI323256B (en)
WO (1) WO2004056369A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2401319T3 (en) * 2002-12-20 2013-04-18 Glaxo Group Limited New benzazepine derivative
CA2543287A1 (en) * 2003-10-23 2005-05-06 F.Hoffmann-La Roche Ag Benzazepine derivatives as mao-b inhibitors
GB0329214D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
GB0405628D0 (en) * 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) * 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
WO2005123723A1 (en) * 2004-06-18 2005-12-29 Glaxo Group Limited 3-cycloalkylbenzazepines as histamine h3 antagonists
GB0418267D0 (en) * 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
US7560453B2 (en) 2005-01-07 2009-07-14 Glaxo Group Limited 6-(2, 3, 4, 5-tetrahydro-1H-benzo [D] azepin-7-yloxy) -nicotamide derivatives as radio labelled ligands
GB0513886D0 (en) 2005-07-06 2005-08-10 Glaxo Group Ltd Novel compounds
JP2009506069A (en) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド Neurogenesis through modulation of muscarinic receptors
WO2007045989A1 (en) * 2005-10-20 2007-04-26 Pfizer Limited Pyridyl derivatives useful as h3 ligands
US7943605B2 (en) 2005-10-27 2011-05-17 Ucb Pharma S.A. Compounds comprising a lactam or a lactam derivative moiety, processes for making them, and their uses
CA2629232A1 (en) * 2005-11-18 2007-05-24 F. Hoffmann-La Roche Ag Azaindole-2-carboxamide derivatives
AU2007256931B2 (en) * 2006-05-30 2013-01-24 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine H3 receptor
WO2007149728A2 (en) * 2006-06-20 2007-12-27 Alcon Research, Ltd. Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma
US9108948B2 (en) * 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
SG173312A1 (en) 2006-06-23 2011-08-29 Abbott Lab Cyclopropyl amine derivatives as histamin h3 receptor modulators
GB2441014A (en) * 2006-09-14 2008-02-20 Glaxo Group Ltd Polymorphic form of 6-(3-cyclobuty1-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide hydrochloride for use in therapy
CL2008000597A1 (en) * 2007-03-01 2008-09-05 Glaxo Group Ltd Dosage form comprising 6- (3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo [d] azepin-7-yl oxy) -N-methyl nicotinamide, a stabilizer and a carrier; preparation process; and its use to treat neurological diseases.
CL2008000596A1 (en) * 2007-03-01 2008-09-05 Glaxo Group Ltd Dosage form comprising 1- (6 - [(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl) oxy] -3-pyridinyl) -2-pyrrolidinone, a stabilizer an excipient; preparation process; and its use to treat neurological diseases.
HUE036704T2 (en) 2007-05-22 2018-07-30 Wyeth Llc Improved processes for making hydrazides
JP5379796B2 (en) * 2007-09-06 2013-12-25 グラクソ グループ リミテッドGlaxo Group Limited Piperazine derivatives having affinity for histamine H3 receptor
US8383657B2 (en) 2007-12-21 2013-02-26 Abbott Laboratories Thiazolylidine urea and amide derivatives and methods of use thereof
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria
US9186353B2 (en) * 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
WO2011051423A1 (en) 2009-11-02 2011-05-05 Glaxo Group Limited Treatment or prophylaxis of dementia, neurodegenerative disorders, schizophrenia, adhd, somnolence or epilepsy
WO2011083316A1 (en) * 2010-01-08 2011-07-14 Takeda Pharmaceutical Company Limited Benzazepine derivatives for the treatment of central nervous system disorders
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
HUE025163T2 (en) * 2011-02-23 2016-02-29 Suven Life Sciences Ltd Novel compounds as histamine h3 receptor ligands
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
PE20140976A1 (en) 2011-03-14 2014-08-28 Boehringer Ingelheim Int Benzodioxan inhibitors of leukotriene producion
EP2734516B1 (en) 2011-07-19 2015-06-17 Boehringer Ingelheim International GmbH Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
CN104114538B (en) * 2012-01-16 2016-04-13 葛兰素史克知识产权发展有限公司 Therepic use
WO2013107336A1 (en) * 2012-01-16 2013-07-25 Glaxosmithkline Intellectual Property Development Limited Therapeutic uses
CA2866471A1 (en) 2012-03-06 2013-09-12 Boehringer Ingelheim International Gmbh Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
EP2885285B1 (en) * 2012-07-17 2016-10-19 Boehringer Ingelheim International GmbH Pyrazole drivatives which inhibit leukotriene production
US9303018B2 (en) 2013-07-15 2016-04-05 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
US9573957B2 (en) 2013-07-15 2017-02-21 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
WO2016123629A1 (en) * 2015-01-30 2016-08-04 Vanderbilt University Indazole and azaindazole substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CA974989A (en) 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
US4233217A (en) * 1968-03-11 1980-11-11 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H, 3 benzazepines
DE2207430C3 (en) 1972-02-14 1982-05-13 Pennwalt Corp., 19102 Philadelphia, Pa., Us
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
US4206210A (en) * 1977-01-19 1980-06-03 Smithkline Corporation Alkylthio-7,8-dihdroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines having dopaminergic activity
US4843081A (en) * 1984-09-04 1989-06-27 Rorer Pharmaceutical Corporation Aryl and heteroaryl substituted cycloalkyl compounds
US5175157A (en) * 1985-11-27 1992-12-29 Boehringer Ingelheim Gmbh Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
JPS6394239A (en) 1986-10-08 1988-04-25 Konica Corp Silver halide photographic sensitive material having improved stability of dye image
PH27337A (en) * 1987-03-27 1993-06-08 Schering Corp Substituted benzazepines their preparation and pharmaceutical compositions containing them
DE3717561A1 (en) 1987-05-25 1988-12-08 Thomae Gmbh Dr K Indole, isoquinoline and benzazepine derivatives, these drug compounds containing and methods for their production
DK325188D0 (en) 1988-06-15 1988-06-15 Novo Industri As To novel benzazepine derivatives
FR2642756B1 (en) 1989-02-07 1994-03-04 Sanofi Cycloaminoalkoxyphenyle derivatives, method of preparing them and pharmaceutical compositions containing or veterinarians
US4959374A (en) * 1989-07-06 1990-09-25 Beecham Group P.L.C. Novel compounds
ZA9104536B (en) 1990-06-15 1992-03-25 Schering Corp 8-lower alkyl-5-cycloalkyl or 5-cycloakenyl substituted benzazepines and pharmaceutical compositions containing them
TW197435B (en) 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
AU1927992A (en) 1991-06-21 1993-01-25 Smithkline Beecham Plc Medicaments
GB9116824D0 (en) 1991-08-05 1991-09-18 Smithkline Beecham Corp Chemical compounds
GB9119467D0 (en) 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
JPH05194406A (en) 1991-11-12 1993-08-03 Yoshitomi Pharmaceut Ind Ltd New amide compound
US5241065A (en) 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
JPH05239024A (en) 1992-02-28 1993-09-17 Takeda Chem Ind Ltd Condensed heterocyclic carboxylic acid derivative, its production, intermediate and pharmaceuticals
US5364791A (en) 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
CA2135644C (en) * 1992-05-14 2009-01-27 Elisabetta Vegeto Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
DE4332168A1 (en) 1993-02-22 1995-03-23 Thomae Gmbh Dr K Cyclic derivatives, pharmaceutical compositions containing these compounds and process for their preparation
SE9300657D0 (en) 1993-02-26 1993-02-26 Astra Ab New compounds
US5387685A (en) 1993-07-16 1995-02-07 American Cyanamid Co MDR reversal agents
AU1090795A (en) 1993-11-12 1995-05-29 Cell Therapeutics, Inc. Method for preventing tissue injury from hypoxia
AU704114B2 (en) 1993-11-18 1999-04-15 Siga Technologies, Inc. Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
DE4429079A1 (en) 1994-08-17 1996-02-22 Thomae Gmbh Dr K Cyclic urea derivatives, pharmaceutical compositions containing them and processes for their preparation
DE19530996A1 (en) 1995-08-23 1997-02-27 Boehringer Mannheim Gmbh Cyclic guanidines, methods for their preparation and pharmaceutical compositions
EP0920417A4 (en) 1996-08-15 1999-12-29 Smithkline Beecham Corp Il-8 receptor antagonists
US5932590A (en) 1996-12-05 1999-08-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0952826B1 (en) 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease
GB9724372D0 (en) 1997-11-18 1998-01-14 Smithkline Beecham Plc Novel compounds
US6348478B1 (en) 1997-11-20 2002-02-19 Teijin Limited Biphenylamidine derivatives
AU745855B2 (en) 1998-02-02 2002-04-11 Lg Chemical Ltd. Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
EP0937723A1 (en) 1998-02-18 1999-08-25 Boehringer Mannheim Gmbh Novel sulfonamides, process for their preparation and medicaments containing them
PL343896A1 (en) 1998-04-20 2001-09-10 Basf Ag New substituted amides, their production and their use
BR9909994A (en) 1998-04-29 2000-12-26 Smithkline Beecharm P L C MRS quinolines used as inhibitors and bactericides
EP0982300A3 (en) * 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
GB9816982D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
BR9914370A (en) 1998-10-08 2001-11-27 Smithkline Beecham Plc Derivatives useful tetraidrobenzazepina comomoduladores receptors for dopamine D3 (antipsychotic agents)
AU6123699A (en) 1998-10-16 2000-05-08 Takeda Chemical Industries Ltd. Nitrogenous fused heterocycle compounds, process for the preparation thereof andagents containing the same
IL142816D0 (en) 1998-12-24 2002-03-10 Du Pont Pharm Co SUCCINOYLAMINO BENZODIAZEPINES AS INHIBITORS OF Aβ PROTEIN PRODUCTION
GB9914255D0 (en) 1999-06-18 1999-08-18 Lilly Forschung Gmbh Pharmaceutical compounds
EP1237547A2 (en) 1999-07-09 2002-09-11 Isis Innovation Limited Compounds for inhibiting diseases and preparing cells for transplantation
AT254614T (en) * 1999-08-06 2003-12-15 Hoffmann La Roche Tetrahydro benzo (d) azepine and their use as metabotrope glutamate receptor antagonists
JP2003513958A (en) 1999-11-09 2003-04-15 イーライ・リリー・アンド・カンパニー β- amyloid peptide release and / or useful β- amino acid compounds to inhibit the synthesis
EP1254898A4 (en) 2000-01-26 2003-03-12 Ono Pharmaceutical Co Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
JP2001226269A (en) 2000-02-18 2001-08-21 Takeda Chem Ind Ltd Melanin-concentrating hormone antagonist
AT310733T (en) 2000-04-21 2005-12-15 Pfizer Prod Inc Thyroid receptor ligands
AU2001259592B2 (en) 2000-05-11 2005-02-24 Bristol-Myers Squibb Co. Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
EP1283199A4 (en) * 2000-05-16 2003-12-17 Takeda Chemical Industries Ltd Melanin-concentrating hormone antagonist
JP2002371059A (en) * 2000-05-16 2002-12-26 Takeda Chem Ind Ltd Melanin-agglutinating hormone antagonist
US20040063699A1 (en) * 2000-07-04 2004-04-01 Naoki Tarui Gpr14 antagonist
AU7775001A (en) 2000-08-10 2002-02-25 Takeda Chemical Industries Ltd Use of polypeptide
EP1331010A4 (en) 2000-08-25 2008-08-06 Takeda Pharmaceutical Preventives and remedies for central nervous system diseases
MXPA03004243A (en) 2000-11-14 2004-03-16 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents).
UA77165C2 (en) 2000-11-17 2003-08-15 Lilly Co Eli (n)-((s)-2-hydroxy-3-methyl-butyryl)-1-(l-alaninyl)-(s)-1-amino-3-methyl-4,5,6,7-tetrahydro-2h-3-benzazepin-2-one dihydrate, processes for manufacturing and pharmaceutical composition
FR2819512B1 (en) 2001-01-18 2003-02-21 Servier Lab Novel cyclo [d] azepane compounds, process for their preparation and pharmaceutical compositions containing them
BR0206636A (en) 2001-02-02 2004-02-25 Squibb Bristol Myers Co Composition and antiviral activity of substituted azaindoloxoacetic piperazine derivatives
WO2003041641A2 (en) 2001-11-09 2003-05-22 Bristol-Myers Squibb Company Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
US7196108B2 (en) 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
BR0308787A (en) 2002-04-26 2005-01-11 Pfizer Prod Inc N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
MXPA04010550A (en) 2002-04-26 2005-01-25 Pfizer Prod Inc Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors.
AU2003256793A1 (en) * 2002-08-20 2004-03-11 Eli Lilly And Company Substituted azepines as histamine h3 receptor antagonists, preparation and therapeutic uses
SI2208727T1 (en) 2002-09-19 2012-11-30 Lilly Co Eli Diaryl ethers as opioid receptor antagonist
GB0224083D0 (en) 2002-10-16 2002-11-27 Glaxo Group Ltd Novel compounds
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
ES2401319T3 (en) * 2002-12-20 2013-04-18 Glaxo Group Limited New benzazepine derivative
CA2512000C (en) 2002-12-26 2011-08-09 Eisai Co., Ltd. Selective estrogen receptor modulator
MXPA05007937A (en) 2003-02-07 2005-09-30 Warner Lambert Co Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents.
EP1663868A2 (en) 2003-08-08 2006-06-07 Glaxo Group Limited Process for preparing radiolabelled compounds
CA2543287A1 (en) 2003-10-23 2005-05-06 F.Hoffmann-La Roche Ag Benzazepine derivatives as mao-b inhibitors
GB0329214D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Novel compounds
EP1694334B1 (en) 2003-12-18 2011-10-19 Abbott GmbH & Co. KG Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor
GB0405628D0 (en) * 2004-03-12 2004-04-21 Glaxo Group Ltd Novel compounds
GB0408083D0 (en) * 2004-04-08 2004-05-12 Glaxo Group Ltd Novel compounds
WO2005123723A1 (en) * 2004-06-18 2005-12-29 Glaxo Group Limited 3-cycloalkylbenzazepines as histamine h3 antagonists
GB0418267D0 (en) * 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
DE102005042672B4 (en) 2005-09-08 2009-10-01 Leica Microsystems Cms Gmbh Photosensor chip, laser microscope with photosensor chip and method for reading out a photosensor chip

Also Published As

Publication number Publication date
JP5315299B2 (en) 2013-10-16
NO20053384L (en) 2005-09-15
RU2423353C1 (en) 2011-07-10
PL377315A1 (en) 2006-01-23
NO331068B1 (en) 2011-09-26
EP2133340B1 (en) 2013-01-16
US8207331B2 (en) 2012-06-26
KR100897642B1 (en) 2009-05-14
KR20070089762A (en) 2007-08-31
MY138478A (en) 2009-06-30
BR0317483A (en) 2005-11-16
CY1109558T1 (en) 2014-08-13
NO332218B1 (en) 2012-07-30
EP1572215B1 (en) 2009-09-02
ES2333008T3 (en) 2010-02-16
PT1572215E (en) 2009-12-09
EP2186516B1 (en) 2013-01-16
DK1572215T3 (en) 2010-01-11
CA2509413C (en) 2012-05-01
CA2509413A1 (en) 2004-07-08
JP2006512412A (en) 2006-04-13
ES2401319T3 (en) 2013-04-18
KR100765027B1 (en) 2007-10-09
RU2009138602A (en) 2011-04-27
NO20110408L (en) 2005-09-15
IL169091A (en) 2011-11-30
EG25204A (en) 2011-11-14
DE60329123D1 (en) 2009-10-15
TW200500344A (en) 2005-01-01
WO2004056369A1 (en) 2004-07-08
NO20053384D0 (en) 2005-07-12
EP2186516A1 (en) 2010-05-19
TWI323256B (en) 2010-04-11
US7704994B2 (en) 2010-04-27
IS7941A (en) 2005-07-18
US7696193B2 (en) 2010-04-13
JP2010248239A (en) 2010-11-04
US20100145040A1 (en) 2010-06-10
AU2003294909B2 (en) 2007-05-17
IS2907B (en) 2014-11-15
US20060040918A1 (en) 2006-02-23
NZ540148A (en) 2007-11-30
EP1572215A1 (en) 2005-09-14
MA27582A1 (en) 2005-10-03
US20070299056A1 (en) 2007-12-27
ES2401216T3 (en) 2013-04-17
PL397229A1 (en) 2012-02-27
AU2003294909A1 (en) 2004-07-14
RU2005122932A (en) 2006-04-10
AR042542A1 (en) 2005-06-22
MXPA05006567A (en) 2005-08-16
IL202827A (en) 2011-08-31
RU2388752C2 (en) 2010-05-10
HK1085647A1 (en) 2010-04-16
EP2133340A1 (en) 2009-12-16
US7799773B2 (en) 2010-09-21
US20090105226A1 (en) 2009-04-23
JP4584831B2 (en) 2010-11-24
SI1572215T1 (en) 2010-01-29
PL220722B1 (en) 2015-12-31
IL169091D0 (en) 2007-07-04
KR20050088195A (en) 2005-09-02

Similar Documents

Publication Publication Date Title
DK2308507T3 (en) Methods for the treatment of preeclampsia
EG25204A (en) Benzo diazepine derivatives for the treatment of neurological disorders
DE60239009D1 (en) Test method for finding potential medicaments for the treatment of inflammatory diseases
DE60330485D1 (en) For the treatment of diabetes
DK1248606T3 (en) Use of fumaric acid derivatives for the treatment of mitochondrial-related diseases
DE60019598D1 (en) Compounds for the treatment of sexual functional disorders
DK1830843T3 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
DE60230425D1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
DE60323090D1 (en) 1h-imidazoä4,5-cüchinoline derivatives for the treatment of protein kinase-dependent diseases
DE60218493D1 (en) Substituted 7-aza-ä2.2.1übicycloheptane for the treatment of diseases
DK1567488T3 (en) Hydroxyethylamine derivatives for the treatment of Alzheimer's disease
DK1343773T3 (en) Thiazole derivatives for the treatment of PPAR-related disorders
DK1401498T3 (en) Anti-NGF antibodies for the treatment of various diseases
DE60227709D1 (en) The use of c-criteria for the treatment of autoimmune diseases
DK1373215T3 (en) Gelanamycin derivatives suitable for the treatment of cancer
DE60316779D1 (en) Thiadiazolylpiperazine derivatives suitable for the treatment of bzw. prevention of pain
DE60236413D1 (en) Inhibitors of hmgb1 for the treatment of tissue diseases
DK1556342T3 (en) Phenethanolamine derivative for the treatment of respiratory diseases
DK1656346T3 (en) 1,2,3,4-tetra-substituted indole for the treatment of respiratory diseases
DE60124576D1 (en) Compounds use for the treatment of inflammatory diseases
DE60325209D1 (en) Diarylute derivatives suitable for the treatment of protein kinase-dependent diseases
DE69940131D1 (en) Agent for the treatment of diseases of the esophagus
DE60204722D1 (en) Quinazoline derivatives for the treatment of t-cell-mediated diseases
DE60233414D1 (en) Combinations for the treatment of inflammatory diseases
DK1385519T3 (en) Tiotropium salts for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1572215

Country of ref document: EP